Litcius/Paper detail

RAC1high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis

Xiaoli Shi, Wenwei Chen, Yefeng Yin, Hengsong Cao, Xinyi Wang, Xinyi Wang, Wangjie Jiang, Qing Li, Xiangcheng Li, Yue Yu, Xuehao Wang, Xuehao Wang

2024Cancer Letters13 citationsDOI

Topics & Concepts

NKG2DRAC1Cancer researchNatural killer cellImmunotherapyCytotoxic T cellCancer immunotherapyHepatocellular carcinomaLiver cancerBiologyDownregulation and upregulationCellImmune systemImmunologyGeneSignal transductionCell biologyIn vitroGeneticsBiochemistryImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersImmune cells in cancer
RAC1high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis | Litcius